Literature DB >> 18188037

Efficiency of hydroxychloroquine in the treatment of granulomatous complications in chronic granulomatous disease.

Jean-Benoit Arlet1, Achile Aouba, Felipe Suarez, Stephane Blanche, Dominique Valeyre, Alain Fischer, Diane Damotte, Christophe Cellier, Olivier Hermine.   

Abstract

Chronic granulomatous disease (CGD) represents a group of genetic disorders in which impaired intracellular microbial killing by phagocytes leads to recurrent bacterial and fungal infections and granuloma formation. Granulomatous lesions involved gastrointestinal tract in more than one-third of all CGD patients, with various clinical presentations, and may be life threatening. Corticosteroid therapy may relieve symptoms but increase the risk of infections in such immunocompromised patients. We report here the first successful management, with hydroxychloroquine therapy alone, of a 29-year-old CGD man with severe gastric granulomatous involvement. Hydroxychloroquine appears to be a safe and effective alternative treatment of granulomas in CGD patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18188037     DOI: 10.1097/MEG.0b013e328277ef5f

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  5 in total

1.  Killing of Escherichia coli by Crohn's Disease Monocyte-derived Macrophages and Its Enhancement by Hydroxychloroquine and Vitamin D.

Authors:  Paul K Flanagan; Direkrit Chiewchengchol; Helen L Wright; Steven W Edwards; Abdullah Alswied; Jack Satsangi; Sreedhar Subramanian; Jonathan M Rhodes; Barry J Campbell
Journal:  Inflamm Bowel Dis       Date:  2015-07       Impact factor: 5.325

2.  Liquid Silicone-Induced Extensive and Debilitating Granulomatosis Responding to Hydroxychloroquine.

Authors:  Nargis Jilani; Javeria Shabbir; Elena Nemytova
Journal:  Case Rep Rheumatol       Date:  2019-07-24

Review 3.  Hyperinflammation in chronic granulomatous disease and anti-inflammatory role of the phagocyte NADPH oxidase.

Authors:  Michela G Schäppi; Vincent Jaquet; Dominique C Belli; Karl-Heinz Krause
Journal:  Semin Immunopathol       Date:  2008-05-29       Impact factor: 11.759

4.  Managing Inflammatory Manifestations in Patients with Chronic Granulomatous Disease.

Authors:  Alessandra Magnani; Nizar Mahlaoui
Journal:  Paediatr Drugs       Date:  2016-10       Impact factor: 3.930

Review 5.  Aspergillosis in Chronic Granulomatous Disease.

Authors:  Jill King; Stefanie S V Henriet; Adilia Warris
Journal:  J Fungi (Basel)       Date:  2016-05-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.